Qing H. Meng
Impact in
- Biochemistry top 0.5%
- Sulfur Compounds in Biology
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Papers in
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 6
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 9
- Co-authors
- Lingyun Wu (7 shared papers)Shulin Li (10 shared papers)Rui Wang (6 shared papers)Zachary Brownlee (6 shared papers)Arun Satelli (6 shared papers)Elizabeth A. Wagar (18 shared papers)Jianxin Lyu (11 shared papers)John Krahn (7 shared papers)
- Journals
- Clinica Chimica Acta (13 papers)Clinical Chemistry (10 papers)Clinical Biochemistry (10 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (6 papers)Cancer Research (5 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Qing H. Meng
132 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 150
- Biochemistry 543
- Cancer Research 964
- Clinical Biochemistry 376
- Oncology 925
- Physiology 576
Countries citing papers authored by Qing H. Meng
This map shows the geographic impact of Qing H. Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing H. Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing H. Meng more than expected).
Fields of papers citing papers by Qing H. Meng
This network shows the impact of papers produced by Qing H. Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing H. Meng. The network helps show where Qing H. Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Qing H. Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 314 | |
| 2 | 2014 | 190 | |
| 3 | 2006 | 165 | |
| 4 | 2016 | 154 | |
| 5 | 2014 | 152 | |
| 6 | 2014 | 139 | |
| 7 | 2010 | 126 | |
| 8 | 2007 | 120 | |
| 9 | 2017 | 113 | |
| 10 | 2021 | 110 | |
| 11 | 2014 | 99 | |
| 12 | 2007 | 95 | |
| 13 | 2011 | 93 | |
| 14 | 2014 | 84 | |
| 15 | 2013 | 77 | |
| 16 | 2012 | 75 | |
| 17 | 2014 | 70 | |
| 18 | 2008 | 69 | |
| 19 | 2018 | 62 | |
| 20 | 2017 | 62 |
About Qing H. Meng
Qing H. Meng is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 148 papers that have together received 4.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (11 papers), Cancer-related molecular mechanisms research (10 papers), Clinical Laboratory Practices and Quality Control (10 papers), MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers), Cancer Cells and Metastasis (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Biochemistry (543 citations), Cancer Research (964 citations), Clinical Biochemistry (376 citations), Oncology (925 citations) and Physiology (576 citations). Qing H. Meng has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lingyun Wu, Shulin Li, Rui Wang, Zachary Brownlee, Arun Satelli, Elizabeth A. Wagar, Jianxin Lyu, John Krahn, Abhisek Mitra and Guangdong Yang. Their work appears in journals such as Clinica Chimica Acta, Clinical Chemistry, Clinical Biochemistry, Clinical Chemistry and Laboratory Medicine (CCLM) and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.